"The Report BioLingus AG -
Product Pipeline Review - 2016 provides information on pricing,
market analysis, shares, forecast, and company profiles for key
industry participants. - MarketResearchReports.biz"
Global
Markets Directs, BioLingus AG - Product Pipeline Review - 2016,
provides an overview of the BioLingus AGs pharmaceutical research and
development focus.
The
report provides comprehensive information on the therapeutics under
development by BioLingus AG, complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and the dormant and discontinued
projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
View
Report @ http://www.marketresearchreports.biz/analysis/928079
Scope
-
The report provides a snapshot of the pipeline therapeutic landscape
of BioLingus AG
-
The report provides overview of BioLingus AG including its business
description, key facts, and locations and subsidiaries
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report assesses BioLingus AGs pipeline therapeutics based on drug
target, mechanism of action (MoA), route of administration (RoA) and
molecule type
-
The report features BioLingus AGs out-licensed and partnered product
portfolio and summarizes its dormant and discontinued projects
Reasons
to buy
-
Evaluate BioLingus AGs strategic position with total access to
detailed information on its product pipeline
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for BioLingus AG
-
Identify potential new clients or partners in the target demographic
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
BioLingus AGs pipeline depth and focus of pipeline therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
Get
Sample Copy Of This Report @
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report
Coverage 5
BioLingus AG Snapshot 6
BioLingus AG Overview 6
Key Facts 6
BioLingus AG - Research and
Development Overview 7
Key Therapeutic Areas 7
BioLingus AG - Pipeline Review 9
Pipeline Products by Stage of
Development 9
Pipeline Products - Monotherapy 10
BioLingus AG - Pipeline Products
Glance 11
BioLingus AG - Early Stage
Pipeline Products 11
Preclinical Products/Combination
Treatment Modalities 11
Discovery Products/Combination
Treatment Modalities 12
BioLingus AG - Unknown Stage
Pipeline Products 13
Unknown Products/Combination
Treatment Modalities 13
BioLingus AG - Drug Profiles 14
aldesleukin - Drug Profile 14
Product Description 14
Mechanism Of Action 14
R&D Progress 14
Cellular Immunotherapy to Target
Survivin for Oncology - Drug Profile 15
Product Description 15
Mechanism Of Action 15
R&D Progress 15
exenatide biobetter - Drug Profile
16
Product Description 16
Mechanism Of Action 16
R&D Progress 16
interferon alfa biobetter - Drug
Profile 17
Product Description 17
Mechanism Of Action 17
R&D Progress 17
interferon gamma - Drug Profile 18
Product Description 18
Mechanism Of Action 18
R&D Progress 18
interleukin 2 - Drug Profile 19
Product Description 19
Mechanism Of Action 19
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment